KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Cost of Revenue (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Cost of Revenue for 16 consecutive years, with $26.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 1575.54% to $26.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $34.1 million, a 242.05% increase, with the full-year FY2025 number at $34.1 million, up 281.73% from a year prior.
  • Cost of Revenue was $26.2 million for Q4 2025 at Biolife Solutions, up from $2.5 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $26.2 million in Q4 2025 to a low of -$3.9 million in Q4 2022.
  • A 5-year average of $4.8 million and a median of $3.7 million in 2023 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: crashed 182.23% in 2022, then skyrocketed 1575.54% in 2025.
  • Biolife Solutions' Cost of Revenue stood at $4.8 million in 2021, then plummeted by 182.23% to -$3.9 million in 2022, then soared by 393.2% to $11.5 million in 2023, then tumbled by 86.41% to $1.6 million in 2024, then surged by 1575.54% to $26.2 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Cost of Revenue are $26.2 million (Q4 2025), $2.5 million (Q3 2025), and $2.7 million (Q2 2025).